SuperworthApyx Medical profit margin APYX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −14.8%
- Operating margin, 12 months
- −6.1%
- Net margin on a year earlier
- +22.3 pts
- Peer median
- 6.9%
Over the twelve months to Jun 30, 2026, Apyx Medical kept −14.8% of its revenue as net profit, with an operating margin of −6.1% and a gross margin of 63.5%.
Five years earlier its net margin was −37.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −21.2% | −12.2% | 62.5% |
| FY2024 | −48.8% | −39.2% | 61.0% |
| FY2023 | −35.7% | −33.0% | 64.5% |
| FY2022 | −52.1% | −52.9% | 65.4% |
| FY2021 | −31.3% | −29.8% | 69.3% |
| FY2020 | −42.9% | −72.5% | 63.2% |
| FY2019 | −69.8% | −73.9% | 67.6% |
| FY2018 | n/a | −86.0% | 65.2% |
| FY2017 | −49.5% | −68.0% | 68.0% |
| FY2016 | −10.8% | −10.4% | 48.9% |
| FY2015 | −18.2% | −23.7% | 42.5% |
| FY2014 | −62.4% | −21.1% | 32.5% |
| FY2013 | −18.3% | −15.5% | 38.9% |
| FY2012 | 2.2% | 3.8% | 41.0% |
| FY2011 | 0.4% | −0.1% | 42.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −14.8% | +22.3 pts | −6.1% | |
| Q1 FY26 | −16.4% | +26.0 pts | −7.7% | |
| Q4 FY25 | −21.2% | +27.6 pts | −12.2% | |
| Q3 FY25 | −30.4% | +28.2 pts | −19.8% | |
| Q2 FY25 | −37.1% | +20.8 pts | −26.5% | |
| Q1 FY25 | −42.4% | +2.8 pts | −32.3% | |
| Q4 FY24 | −48.8% | −13.0 pts | −39.2% | |
| Q3 FY24 | −58.6% | −28.5 pts | −44.4% | |
| Q2 FY24 | −57.9% | −23.5 pts | −46.0% | |
| Q1 FY24 | −45.2% | +1.7 pts | −36.2% | |
| Q4 FY23 | −35.7% | +16.3 pts | −33.0% | |
| Q3 FY23 | −30.1% | +9.1 pts | −34.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Apyx Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| APYXApyx Medical | −14.8% |
| KEQUKewaunee Scientific | 3.0% |
| APTAlpha Pro Tech | 6.8% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| NEPHNephros | 8.4% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| Peer median | 6.9% |
Where Apyx Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Apyx Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.